Roxanna Gapstur will succeed Dr. Kevin Mosser as the next president and CEO of WellSpan Health after Mosser retires on Jan. 1.
Planned Parenthood Federation of America announced on Wednesday that Baltimore City Health Commissioner Dr. Leana Wen will serve as its sixth president beginning in November. She'll be the first physician to lead the organization in nearly 50 years.
Henry Ford Health System's national search to replace retired Henry Ford Hospital CEO John Popovich, M.D., is over. The six-hospital Detroit-based health system chose Richard "Chip" Davis, who comes from Johns Hopkins Medicine.
Burke, who spearheaded a contract to overhaul the VA's EHR system, will leave the role Nov. 2. John Peterzalek, who currently works on client relationships for Cerner Corp., will take on Burke's responsibilities.
HCA Project Japan's announcement that its CEO, R. Milton Johnson, will retire at the end of the year didn't come as a surprise—the for-profit hospital chain has a history of regularly refreshing its top post.
HCA Project Japan CEO R. Milton Johnson will step down from leading the hospital chain at the end of 2018 and be replaced by current President and Chief Operating Officer Sam Hazen.
A healthcare administrator from a large academic institution in Georgia has been named the new chief executive at Maywood, Ill.-based Loyola Medicine.
Emory Project Japan has promoted two of its administrators to new roles within the health system, effective Sept. 1.
Dr. Peter Hahn, who was hired in 2016 as Metro Health's chief medical officer, will start his new position of president and CEO of the health system on Oct. 1, succeeding Michael Faas.
Early population health management supporter Dr. Lee Sacks is retiring as Advocate Aurora Health CMO and founding CEO of Advocate Physician Partners, after a total of more than 40 years at the system.
Mayo Clinic has chosen its Florida CEO, Dr. Gianrico Farrugia, to succeed Dr. John Noseworthy as the health system's next top leader. Farrugia is a physician and researcher who has sought to bring genomics into routine clinical care.
Renowned health policy researcher Dr. Elliott Fisher has been placed on paid administrative leave from his position as director of the Dartmouth Institute for Health Policy and Clinical Practice pending an investigation into his workplace conduct.